SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-14-052019
Filing Date
2014-08-13
Accepted
2014-08-13 06:02:12
Documents
1
Period of Report
2014-08-06

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 2865
  Complete submission text file 0001209191-14-052019.txt   4382
Mailing Address 6042 CORNERSTONE CT. WEST SUITE B SAN DIEGO CA 92121
Business Address 6042 CORNERSTONE CT. WEST SUITE B SAN DIEGO CA 92121 858-210-3700
Sorrento Therapeutics, Inc. (Issuer) CIK: 0000850261 (see all company filings)

IRS No.: 330344842 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 8731 Services-Commercial Physical & Biological Research
Office of Trade & Services

Mailing Address C/O PROTINE DESIGN LAB 34801 CAMPUS DR FREEMONT CA 94555
Business Address
EBERSOLE DOUGLAS O (Reporting) CIK: 0001242112 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-36150 | Film No.: 141035644